Recruiting

A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(2 sites)

China

The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality